Cancer-related distress contributes to missed oncology appointments, infusion disruptions, and reduced adherence to cancer therapies, yet many community oncology practices lack integrated behavioral health models to address psychosocial barriers to treatment adherence. This quality improvement initiative embedded Collaborative Care–based behavioral health services within community oncology practices and incorporated patient-reported measures of oncology treatment adherence (appointment attendance, infusion continuity, medication adherence, and emergency department utilization) alongside validated distress measures (PHQ-9, GAD-7, FACT-G7) to guide measurement-based behavioral health care planning. Early implementation demonstrates the feasibility of integrating adherence metrics into behavioral health workflows to identify treatment barriers and support patients in remaining engaged with oncology treatment.
Supriya Laknidhi
Collaborative Care Model Archer, J., et al. (2012). Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews.
Lee, S. A., Nam, C. M., Kim, Y. H., et al. (2020). Impact of onset of psychiatric disorders and psychiatric treatment on mortality among patients with cancer. The Oncologist.
Antoni, M. H. (2013). Psychosocial intervention effects on adaptation, disease course, and biobehavioral processes in cancer. Brain, Behavior, and Immunity.